PLCO Trial Etiologic and Early Marker Study

PLCO 试验病因学和早期标志物研究

基本信息

批准号：
8763622
负责人：
Robert Hoover
金额：
$ 191.59万
依托单位：
DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/8763622
关键词：
2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine 8q24 Address Age Aromatic Amines Biochemical Biological Assay Bladder Blood specimen Breast Bronchi Calcium-Sensing Receptors Cancer Etiology Candidate Disease Gene Categories Cells Clinical Collaborations Collection Colon Carcinoma Colonic Adenoma Colorectal Colorectal Adenoma Colorectal Cancer Contracts Cooking Practices Cytogenetics DNA Repair Data Databases Demographic Factors Development Diet Dietary Fiber Disease Disease Marker Division of Cancer Prevention Early Diagnosis Equipment and supply inventories Etiology Food Frequencies Genes Genetic Genetic Markers Genetic Polymorphism Genetic Variation High temperature of physical object Incidence Institutes Insulin-Like Growth Factor I Intake Investigation Kidney Lung Lymphoma Malignant Neoplasms Malignant neoplasm of lung Malignant neoplasm of ovary Malignant neoplasm of prostate Meat Medical Metabolism Modification Molecular Epidemiology Nutritional Pancreas Participant Pathologic Pathway interactions Pleura Predisposition Prostate Questionnaires Recruitment Activity Reporting Research Research Activity Research Personnel Resources Risk Risk Factors SHBG gene Sampling Scientist Screening for Ovarian Cancer Screening for cancer Selenium Serum Smoker Somatomedins Tissue Microarray Tobacco smoke Tobacco use Trachea United States Validation Vegetables Vitamin E adenoma alpha Tocopherol arm calcium intake cancer epidemiology cancer genetics cancer risk cohort cooking cruciferous vegetable follow-up genetic analysis genome wide association study lycopene malignant breast neoplasm meetings member mortality randomized trial research study screening steroid hormone volunteer

项目摘要

The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial is a large randomized trial to determine if screening for these cancers reduces mortality. The Trial is carried out by the NCI under contract with investigators at ten clinical centers in the United States. The study includes approximately 155,000 volunteers (recruited from 1993 through 2001, ages 55-74, equally distributed to the screening and control arms of the Trial). The PLCO Etiology and Early Markers Study (EEMS) supports etiologic and early detection studies of cancers and other conditions. EEMS uses data and samples collected in the context of the PLCO Trial including:1. Baseline demographic and risk factor information on all participants,2. Food Frequency Questionnaires(FFQ) on all participants3. Fractionated blood specimens at each of six screening rounds from screened participants,4. Buccal cell samples from control participants, and5. Information on all-cancer incidence and selected other medical conditions.Investigations in PLCO EEMS have shown dietary-related factors associated with adenoma risk, including dietary fiber, meat cooking practices, serum selenium, low calcium intake, and a gene variant in the calcium-sensing receptor. Tobacco use was strongly related to adenoma risk, with evidence of risk modification by genes involved in the metabolism of PAH and aromatic amine constituents of tobacco smoke. Other factors associated with risk of colorectal adenoma included insulin-like growth factors and selected DNA repair-related polymorphisms. Prostate cancer risk was related to vegetable intake, particularly cruciferous vegetables, while dietary and serum lycopene were unrelated to risk. Supplemental vitamin E and serum alpha-tocopherol were related to risk only in smokers, consistent with other reports; serum selenium was also related to risk in smokers only. High-temperature cooked meat containing 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) led to increased risk, while only the highest levels of insulin-like growth factor-1 (IGF-1) were related to prostate cancer. Genetic studies of candidate genes in the PLCO Trial have revealed associations with SNPs in SHBG and risk of prostate cancer. Through the Breast and Prostate Cancer Cohort Consortium (BPC3) are evaluating prostate and breast cancer risks related to gene variants in steroid hormone and insulin-like growth factor pathways. Investigations in BPC3 and the Cancer Genetic Markers of Susceptibility (CGEMS) project are identifying prostate cancer risks associated with gene variants in the 8q24 region. Colon adenoma studies are now being expanded to consider the etiology of colon cancer, also in collaboration with other research groups. Genome wide association studies (GWAS) have been condicted for canccers of the lymphoma, kidney, pancreas, bladder, prostate, breast, and lung.

前列腺癌、肺癌、结直肠癌和卵巢癌 (PLCO) 筛查试验是一项大型随机试验，旨在确定筛查这些癌症是否可以降低死亡率。该试验由 NCI 与美国 10 个临床中心的研究人员签订合同进行。该研究包括大约 155,000 名志愿者（从 1993 年到 2001 年招募，年龄 55-74 岁，平均分配到试验的筛查组和控制组）。 PLCO 病因学和早期标志物研究 (EEMS) 支持癌症和其他疾病的病因学和早期检测研究。 EEMS 使用在 PLCO 试验中收集的数据和样本，包括：1。所有参与者的基线人口统计和风险因素信息，2。对所有参与者进行食物频率问卷（FFQ）3。六轮筛选中每一轮的血液样本均来自筛选的参与者，4。来自对照参与者的口腔细胞样本，以及5。有关所有癌症发病率和选定其他医疗状况的信息。PLCO EEMS 的调查显示，与腺瘤风险相关的饮食相关因素包括膳食纤维、肉类烹饪方法、血清硒、低钙摄入量以及钙中的基因变异。传感受体。烟草使用与腺瘤风险密切相关，有证据表明参与烟草烟雾中 PAH 和芳香胺成分代谢的基因可以改变风险。与结直肠腺瘤风险相关的其他因素包括胰岛素样生长因子和选定的 DNA 修复相关多态性。前列腺癌风险与蔬菜摄入量有关，尤其是十字花科蔬菜，而饮食和血清番茄红素与风险无关。补充维生素 E 和血清 α-生育酚仅与吸烟者的风险相关，这与其他报告一致；血清硒也仅与吸烟者的风险相关。含有2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶（PhIP）的高温熟肉会导致风险增加，而只有最高水平的胰岛素样生长因子-1（IGF-1））与前列腺癌有关。 PLCO 试验中候选基因的遗传学研究揭示了性激素结合球蛋白 (SHBG) 中的 SNP 与前列腺癌风险的关联。通过乳腺癌和前列腺癌队列联盟 (BPC3)，正在评估与类固醇激素和胰岛素样生长因子途径的基因变异相关的前列腺癌和乳腺癌风险。 BPC3 和癌症遗传易感性标记 (CGEMS) 项目的研究正在确定与 8q24 区域基因变异相关的前列腺癌风险。结肠腺瘤研究现在正在扩大，以考虑结肠癌的病因学，同时也与其他研究小组合作。全基因组关联研究（GWAS）已被证实可用于淋巴瘤、肾癌、胰腺癌、膀胱癌、前列腺癌、乳腺癌和肺癌。